1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. ReproCELL Acquires Stemgent - iPS Cell Business Unit

M&A Deal Summary

ReproCELL Acquires Stemgent - iPS Cell Business Unit

On September 9, 2014, ReproCELL acquired life science company Stemgent - iPS Cell Business Unit from Asterand Bioscience

Acquisition Highlights
  • This is ReproCELL’s 2nd transaction in the Life Science sector.
  • This is ReproCELL’s 2nd transaction in the United States.

M&A Deal Summary
Date 2014-09-09
Target Stemgent - iPS Cell Business Unit
Sector Life Science
Buyer(s) ReproCELL
Sellers(s) Asterand Bioscience
Deal Type Divestiture

Target

Stemgent - iPS Cell Business Unit

United States
iPS cell research reagent products including mRNA reprogramming kit, xeno-free culture media, and specialty chemicals for cell differentiation, and has established a world-famous, proven and trusted brand in the iPS cell field.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ReproCELL

Yokohama, Japan
Category Company
Founded 2003
Sector Life Science
Employees96
Revenue 3.0B JPY (2025)
DESCRIPTION

ReproCELL provides stem cell research and drug discovery services. ReproCELL was founded in 2003 and is based in Yokohama, Japan.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 2 of 2
Year: 2014 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-04 Reinnervate

Sedgefield, United Kingdom

Reinnervate makes the Alvetex line of 3D cell culture products, which will be combined with Reprocell's induced pluripotent stem cells to produce next-generation tools for drug toxicity, neuroscience, and cancer research.

Buy -

Seller(S) 1

SELLER

Asterand Bioscience

Detroit, Michigan, United States
Category Company
Sector Life Science
DESCRIPTION

Asterand Bioscience is a provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
Country: United States M&A 2 of 2
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-07 BioSeek

South San Francisco, California, United States

BioSeek is a pharmaceutical services.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-11 AdeptBio

Memphis, Tennessee, United States

AdeptBio LLC is specializes in procurement of human tissue specimens.

Buy -
Mergr

Solution for

Product

Company

Legal